HTN and cardiomyopathy Flashcards
1
Q
normal BP
A
- < 120/80
2
Q
stage 1 HTN
A
- SBP 130-139
- DBP 80-89
3
Q
Stage 2 HTN
A
- SBP > 140
- DBP > 90
4
Q
what is the gold standard for HTN dx
A
- ambulatory BP monitoring (ABPM)
- records BP over time, usually 24 hours
- requires mean of 125/75
- daytime mean 130/80
- nighttime mean 110/65
- not used often
5
Q
how to dx HTN
A
- ABPM
- 3 office based readings of >130 and/or > 80 over course of weeks or months
- if pt presents with HTN urgency or emergency
- if pt has >160 SBP or > 100 DBP and has target end organ damage
6
Q
target end organ damage
A
- LVH
- HTN retinopathy
- ischemic CV disease
7
Q
HTN screening
A
- anyone over 18 annually
- anyone with increased risk factors screen semi- annually
8
Q
primary HTN
A
- no underlying cause
- aka essential HTN
- 95% of all HTN
- likely multifactorial cause
9
Q
secondary HTN
A
- 5% of all HTN
- related to an identifiable cause
- common causes- renal disease, cushings, pregnancy, drugs, hyperthyroidism
10
Q
masked HTN
A
- BP that is constantly elevated at out of office measurements
- doesnt meet in office dx criteria
- associated with increased all cause mortality
- increased long term risk of sustained CV morbidity
11
Q
white coat HTN
A
- BP that is consistently elevated at office readings but doesnt meet HTN dx criteria
- need to get BP readings out of office to dx
12
Q
additional screenings for HTN
A
- chem 10- electrolytes and renal fn
- fasting glucose and/or Hb A1C
- CBC
- TSH
- Lipid profile
- EKG (LVH)
- dont need to do routine screenings for secondary causes
13
Q
when do you treat for HTN
A
- when avg office BP is > 140/90
- when out of office avg is > 135/85
- when comorbidities plus out of office avg > 130/80
- lifestyle modifications should be first line but often need medications
- close follow up within 3 mo to monitor progress
14
Q
initial drug tx for HTN
A
- thiazide diuretic
- long acting CCB
- ACEI
- ARB
- no significant difference in CV mortality between the four classes
15
Q
HTN tx for AA
A
- thiazide diuretic
- CCB
16
Q
HTN for CKD pts
A
- ACE or ARB best tx- delays progression of kidney disease
- ACE avoided in acute kidney disease
17
Q
HTN tx with diabetic nephropathy or non- diabetic kidney disease
A
- ACE or ARB initially
- more aggressive tx required d/t increased CV risk
- often require multiple agents
18
Q
HTN combo tx principles
A
- majority of pts need more than 1 agent
- combo of drugs from different classes better than doubling dose of single agent
- combo of 2 first line agents of dif classes when 20 SBP or 10 DBP away from goal
19
Q
possible HTN combo tx
A
- ACE/ARB + CCB
- ACE/ARB + thiazide (less effective)
- DO NOT combine ACE + ARB
20
Q
resistant HTN
A
- BP that isnt controlled to goal despite adherence to 3 drug regimen of dif classes
- requires at least 4 meds to achieve goal